<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-pharmaceutics-12-00138">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Espinoza</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Silva-Abreu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Clares</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Rodríguez-Lagunas</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Halbaut</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Cañas</surname>
    <given-names>M.-A.</given-names>
   </name>
   <name>
    <surname>Calpena</surname>
    <given-names>A.C.</given-names>
   </name>
  </person-group>
  <article-title>Formulation strategies to improve nose-to-brain delivery of Donepezil</article-title>
  <source>Pharmaceutics</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>64</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics11020064</pub-id>
  <?supplied-pmid 30717264?>
  <pub-id pub-id-type="pmid">30717264</pub-id>
 </element-citation>
</ref>
